BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37416772)

  • 1. FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression.
    Ye M; Hu C; Chen T; Yu P; Chen J; Lu F; Xu L; Zhong Y; Yan L; Kan J; Bai J; Li X; Tian Y; Tang Q
    Int J Biol Sci; 2023; 19(10):3115-3127. PubMed ID: 37416772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β-catenin pathway.
    Lu F; Ye M; Hu C; Chen J; Yan L; Gu D; Xu L; Tian Y; Bai J; Tang Q
    Cancer Sci; 2023 Sep; 114(9):3553-3567. PubMed ID: 37302809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway.
    Chang L; Wu P; Senthilkumar R; Tian X; Liu H; Shen X; Tao Z; Huang P
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):59-72. PubMed ID: 26109148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AZGP1 suppresses the process of colorectal cancer after upregulating FASN expression via mTOR signal pathway.
    Yu W; Ling J; Yu H; Du J; Liu T
    Gen Physiol Biophys; 2020 May; 39(3):239-248. PubMed ID: 32525817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-Specific Downregulation of Fatty Acid Synthase Suppresses Intestinal Adenoma Formation via Coordinated Reprograming of Transcriptome and Metabolism in the Mouse Model of Apc-Driven Colorectal Cancer.
    Drury J; Young LEA; Scott TL; Kelson CO; He D; Liu J; Wu Y; Wang C; Weiss HL; Fan T; Gentry MS; Sun R; Zaytseva YY
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m6A-IGF2BP2-dependent manner.
    Chen J; Ye M; Bai J; Gong Z; Yan L; Gu D; Hu C; Lu F; Yu P; Xu L; Wang Y; Tian Y; Tang Q
    J Transl Med; 2023 Oct; 21(1):741. PubMed ID: 37858219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid synthase regulates invasion and metastasis of colorectal cancer via Wnt signaling pathway.
    Wang H; Xi Q; Wu G
    Cancer Med; 2016 Jul; 5(7):1599-606. PubMed ID: 27139420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism.
    Zhang C; Liao Y; Liu P; Du Q; Liang Y; Ooi S; Qin S; He S; Yao S; Wang W
    Theranostics; 2020; 10(15):6561-6580. PubMed ID: 32550890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid synthase (FASN) inhibits the cervical squamous cell carcinoma (CESC) progression through the Akt/mTOR signaling pathway.
    Lin Q; Jiang Y; Zhou F; Zhang Y
    Gene; 2023 Jan; 851():147023. PubMed ID: 36375657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma.
    Chianese U; Papulino C; Ali A; Ciardiello F; Cappabianca S; Altucci L; Carafa V; Benedetti R
    J Transl Med; 2023 Jan; 21(1):32. PubMed ID: 36650542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FABP5 coordinates lipid signaling that promotes prostate cancer metastasis.
    Carbonetti G; Wilpshaar T; Kroonen J; Studholme K; Converso C; d'Oelsnitz S; Kaczocha M
    Sci Rep; 2019 Dec; 9(1):18944. PubMed ID: 31831821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid binding protein 5 regulates lipogenesis and tumor growth in lung adenocarcinoma.
    Garcia KA; Costa ML; Lacunza E; Martinez ME; Corsico B; Scaglia N
    Life Sci; 2022 Jul; 301():120621. PubMed ID: 35545133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis.
    Tao T; Su Q; Xu S; Deng J; Zhou S; Zhuang Y; Huang Y; He C; He S; Peng M; Hocher B; Yang X
    J Cell Physiol; 2019 Mar; 234(3):3088-3104. PubMed ID: 30221356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth.
    Wei W; Qin B; Wen W; Zhang B; Luo H; Wang Y; Xu H; Xie X; Liu S; Jiang X; Wang M; Tang Q; Zhang J; Yang R; Fan Z; Lyu H; Lin J; Li K; Lee MH
    Signal Transduct Target Ther; 2023 May; 8(1):187. PubMed ID: 37202390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SREBP1/FASN/cholesterol axis facilitates radioresistance in colorectal cancer.
    Jin Y; Chen Z; Dong J; Wang B; Fan S; Yang X; Cui M
    FEBS Open Bio; 2021 May; 11(5):1343-1352. PubMed ID: 33665967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Pathway for Hypoxia-Induced Proliferation and Migration in Human Mesenchymal Stem Cells: Involvement of HIF-1α, FASN, and mTORC1.
    Lee HJ; Ryu JM; Jung YH; Oh SY; Lee SJ; Han HJ
    Stem Cells; 2015 Jul; 33(7):2182-95. PubMed ID: 25825864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "HER2-PI3K/Akt-FASN Axis" regulated malignant phenotype of colorectal cancer cells.
    Li N; Bu X; Wu P; Wu P; Huang P
    Lipids; 2012 Apr; 47(4):403-11. PubMed ID: 22218925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death.
    Yang CS; Matsuura K; Huang NJ; Robeson AC; Huang B; Zhang L; Kornbluth S
    Oncogene; 2015 Jun; 34(25):3264-72. PubMed ID: 25151963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration.
    Zaytseva YY; Harris JW; Mitov MI; Kim JT; Butterfield DA; Lee EY; Weiss HL; Gao T; Evers BM
    Oncotarget; 2015 Aug; 6(22):18891-904. PubMed ID: 25970773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer.
    Tomek K; Wagner R; Varga F; Singer CF; Karlic H; Grunt TW
    Mol Cancer Res; 2011 Dec; 9(12):1767-79. PubMed ID: 21970855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.